Effect of CGRP and sumatriptan on the BOLD response in visual cortex

Journal of Headache and Pain

Volumn 13, Issue 2, 2012, Pages 159-166

  Asghar, Mohammad S ^a   Hansen, Adam E ^a   Larsson, Henrik B W ^a   Olesen, Jes ^a   Ashina, Messoud ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

BOLD; Brain activity; Calcitonin gene related peptide (CGRP); Functional MRI; Headache; Sumatriptan

Indexed keywords

ALPHA CALCITONIN GENE RELATED PEPTIDE; PLACEBO; SUMATRIPTAN SUCCINATE;

ADULT; ARTICLE; BLOOD BRAIN BARRIER; BOLD SIGNAL; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HEADACHE; HUMAN; IN VIVO STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VISUAL CORTEX; VISUAL STIMULATION;

ADULT; CALCITONIN GENE-RELATED PEPTIDE; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INFUSIONS, INTRAVENOUS; INJECTIONS, SUBCUTANEOUS; MAGNETIC RESONANCE IMAGING; MALE; SUMATRIPTAN; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS; VISUAL CORTEX; YOUNG ADULT;

EID: 84859618162     PISSN: 11292369     EISSN: 11292377     Source Type: Journal    
DOI: 10.1007/s10194-011-0415-4     Document Type: Article

References (40)

1. Villalón CM, Olesen J (2009) The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 12:309-323
2. Rosenfeld MG, Mermod JJ, Amara SG, Swanson LW, Sawchenko PE, Rivier J, Vale WW, Evans RM (1983) Production of a novel neuropeptide encoded by the calcitonin gene via tissuespecific RNA processing. Nature 7:129-135 (Pubitemid 13079138)
3. Edvinsson L, Fredholm BB, Hamel E, Jansen I, Verrecchia C (1985) Perivascular peptides relax cerebral arteries concomitant with stimulation of cyclic adenosine monophosphate accumulation or release of an endothelium-derived relaxing factor in the cat. Neurosci Lett 7:213-217 (Pubitemid 15017193)
4. McCulloch J, Uddman R, Kingman TA, Edvinsson L (1986) Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci USA 8:5731-5735 (Pubitemid 16001291)
5. Uddman R, Edvinsson L, Ekblad E, Håkanson R, Sundler F (1986) Calcitonin gene-related peptide (CGRP): perivascular distribution and vasodilatory effects. Regul Pept 8:1-23 (Pubitemid 16045678)
6. Tsai SH, Tew JM, McLean JH, Shipley MT (1988) Cerebral arterial innervation by nerve fibers containing calcitonin generelated peptide (CGRP): I. Distribution and origin of CGRP perivascular innervation in the rat. J Comp Neurol 5:435-444
7. Goadsby PJ, Edvinsson L, Ekman R (1988) Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol 2:193-196 (Pubitemid 18081459)
8. Lassen L, Haderslev P, Jacobsen V, Iversen H, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 2:54-61
9. Asghar MS, Hansen AE, Amin FM, van der Geest RJ, Koning P, Larsson HB, Olesen J, Ashina M (2011) Evidence for a vascular factor in migraine. Ann Neurol 4:635-645
10. Olesen J, Diener H, Husstedt I, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM (2004) Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 3:1104-1110 (Pubitemid 38298990)
11. Ho TW, Mannix LK, Fan X, Assaid C, Furtek C, Jones CJ, Lines CR, Rapoport AM (2008) Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 4:1304-1312 (Pubitemid 351550355)
12. Ho TW, Edvinsson L, Goadsby PJ (2010) CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 10:573-582
13. Petersen K, Nilsson E, Olesen J, Edvinsson L (2005) Presence and function of the calcitonin gene-related peptide receptor on rat pial arteries investigated in vitro and in vivo. Cephalalgia 6:424-432 (Pubitemid 40769861)
14. Asghar MS, Hansen AE, Kapijimpanga T, van der Geest RJ, van der Koning P, Larsson HB, Olesen J, Ashina M (2010) Dilation by CGRP of middle meningeal artery and reversal by sumatriptan in normal volunteers. Neurology 10:1520-1526
15. Kwong K, Belliveau J, Chesler D, Goldberg IE, Weisskoff RM, Poncelet BP, Kennedy DN, Hoppel BE, Cohen MS, Turner R (1992) Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc Natl Acad Sci USA 6:5675-5679
16. Ogawa S, Lee T, Nayak A, Glynn P (1990) Oxygenation-sensitive contrast in magnetic resonance image of rodent brain at high magnetic fields. Magn Reson Med 4:68-78 (Pubitemid 20243866)
17. Buxton R, Wong E, Frank L (1998) Dynamics of blood flow and oxygenation changes during brain activation: the balloon model. Magn Reson Med 6:855-864 (Pubitemid 28237743)
18. Genovese C, Lazar N, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 4:870-878 (Pubitemid 34852500)
19. Petersen K, Birk S, Lassen L, Kruuse C, Jonassen O, Lesko L, Olesen J (2005) The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers. Cephalalgia 2:139-147 (Pubitemid 40193957)
20. Iversen H, Olesen J, Tfelt-Hansen P (1989) Intravenous nitroglycerin as an experimental model of vascular headache. Basic characteristics. Pain 6:17-24 (Pubitemid 19184833)
21. Hoge R, Atkinson J, Gill B, Crelier G, Marrett S, Pike G (1999) Investigation of BOLD signal dependence on cerebral blood flow and oxygen consumption: the deoxyhemoglobin dilution model. Magn Reson Med 11:849-863 (Pubitemid 29521474)
22. Denuelle M, Boulloche N, Payoux P, Fabre N, trotter Y, Géraud G (2011) A PET study of photophobia during spontaneous migraine attacks. Neurology 76(3):213-218
23. Petersen KA, Lassen LH, Birk S, Lesko L, Olesen J (2005) BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation. Clin Pharmacol Ther 3:202-213 (Pubitemid 40269135)
24. Lassen LH, Jacobsen VB, Haderslev PA, Sperling B, Iversen HK, Olesen J, Tfelt-Hansen P (2008) Involvement of calcitonin generelated peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients. J Headache Pain 6:151-157
25. Lennerz JK, Rühle V, Ceppa EP, Neuhuber WL, Bunnett NW, Grady EF, Messlinger K (2008) Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution. J Comp Neurol 3:1277-1299 (Pubitemid 351413572)
26. GuX, Yu L (2007) The colocalization ofCGRP receptor andAMPA receptor in the spinal dorsal horn neuron of rat: a morphological and electrophysiological study. Neurosci Lett 3:237-241
27. Yu Y, Lundeberg T, Yu LC (2002) Role of calcitonin generelated peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats. Regul Pept 1:23-27 (Pubitemid 34001633)
28. Pecile A, Guidobono F, Netti C, Sibilia V, Biella G, Braga PC (1987) Calcitonin gene-related peptide: antinociceptive activity in rats, comparison with calcitonin. Regul Pept 8:189-199 (Pubitemid 17138591)
29. Huang Y, Brodda-Jansen G, Lundeberg T, Yu LC (2000) Antinociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone. Brain Res 8:54-59 (Pubitemid 30468485)
30. Brain SD, Williams TJ, Tippins JR, Morris HR, MacIntyre I (1985) Calcitonin gene-related peptide is a potent vasodilator. Nature 1:54-56 (Pubitemid 15192304)
31. Eftekhari S, Edvinsson L (2010) Possible sites of action of the new calcitonin gene-related peptide receptor antagonists. Ther Adv Neurol Disord 11:369-378
32. Wimalawansa SJ (1996) Calcitonin gene-related peptide and its receptors: molecular genetics, physiology, pathophysiology, and therapeutic potentials. Endocr Rev 17(5):533-585
33. Jansen-Olesen I, Jørgensen L, Engel U, Edvinsson L (2003) Indepth characterization of CGRP receptors in human intracranial arteries. Eur J Pharmacol 11:207-216 (Pubitemid 37464972)
34. Gupta S, Mehrotra S, Avezaat CJJ, Villalón CM, Saxena PR, Maassenvandenbrink A (2006) Characterisation of CGRP receptors in the human isolated middle meningeal artery. Life Sci 6:265-271 (Pubitemid 43804825)
35. Petersen K, Birk S, Doods H, Edvinsson L, Olesen J (2004) Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat. Br J Pharmacol 11:697-704 (Pubitemid 39611605)
36. Humphrey PP, Goadsby PJ (1994) The mode of action of sumatriptan is vascular? A debate. Cephalalgia 12:401-410 (discussion 393)
37. Ahn A, Basbaum A (2005) Where do triptans act in the treatment of migraine? Pain 5:1-4
38. Levy D, Burstein R, Strassman A (2005) Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine. Ann Neurol 11:698-705 (Pubitemid 41552545)
39. Goadsby P, Knight Y (1997) Direct Evidence for Central Sites of Action of Zolmitriptan (311C90). Cephalalgia 5:153-158 (Pubitemid 27257339)
40. Sakai Y, Dobson C, Diksic M, Aubé M, Hamel E (2008) Sumatriptan normalizes the migraine attack-related increase in brain serotonin synthesis. Neurology 2:431-439